Results 321 to 330 of about 466,412 (376)

Prefrontal cortex iron content in neurodegeneration and healthy subjects: A systematic review

Ibrain, EarlyView.
This systematic review summarizes magnetic resonance imaging (MRI)‐based assessments of prefrontal cortex (PFC) iron accumulation in healthy individuals and patients with neurodegenerative diseases. The review includes 12 studies using techniques such as susceptibility‐weighted imaging (SWI), quantitative susceptibility mapping (QSM), and R2* mapping ...
Sana Mohammadi, Sadegh Ghaderi, Masoud Hoseini Pourasl, Farzad Fatehi   +3 more
wiley   +1 more source

Immunomodulatory natural polysaccharide‐based nanoparticles for the treatment of neurodegenerative diseases

Ibrain, EarlyView.
Polysaccharide‐based nanoparticles offer versatile platforms for drug delivery and immune modulation in neurodegenerative diseases. This review highlights their potential in treating Alzheimer's, Parkinson's, and multiple sclerosis, focusing on targeted delivery and neuroinflammation.
Leto‐Aikaterini Tziveleka, Mariafrancesca Cascione, Paolo Pellegrino, Annalisa Bianco, Stefano Leporatti, Valeria De Matteis   +5 more
wiley   +1 more source

Do MRI structured reports with FIGO classifications of leiomyomas contain adequate information for clinical decision making?

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate if structured reports (SR) of pelvic magnetic resonance imaging (MRI) scans using the PALM‐COEIN FIGO (the International Federation of Gynecology & Obstetrics) uterine leiomyomas classification (SR‐FIGO) contain adequate information for clinical decision making compared with narrative reports (NR). Methods Three reporting
Laura Tordjman, Haleh Amirian, Alexandra Alvarez, Sara Shir, Julieta Aristizabal, Patricia Castillo, Prasoon Mohan, Stephanie Delgado, Francesco Alessandrino   +8 more
wiley   +1 more source

Time‐restricted feeding mitigates Alzheimer's disease‐associated cognitive impairments via a B. pseudolongum‐propionic acid‐FFAR3 axis

iMeta, Volume 4, Issue 2, April 2025.
A 4‐month of time‐restricted feeding (TRF) intervention alleviated cognitive impairments in Alzheimer's disease (AD) patients, while a 3‐month TRF regimen improved spatial memory, reduced amyloid‐beta accumulation, and promoted microglial aggregation around plaques in AD mice. Antibiotic‐induced gut microbiota depletion partly abolished TRF's benefits.
Yihang Zhao, Mengzhen Jia, Chen Ding, Bingkun Bao, Hangqi Li, Jiabin Ma, Weixuan Dong, Rui Gao, Xuhui Chen, Jiao Chen, Xiaoshuang Dai, Yuanqiang Zou, Jun Hu, Lin Shi, Xuebo Liu, Zhigang Liu   +15 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Laboratory biomarkers of Multiple Sclerosis (MS)

Clinical Biochemistry, 2022
Multiple Sclerosis (MS) is a neurological disease that affects the central nervous system (CNS). The diagnosis of the disease is quite challenging due to its variation among patients. As a result, the need to enhance diagnostic procedures, evaluate objective prognostic markers and promote effective monitoring of patients' responses to treatment has ...
Jörg Kraus, Borros Arneth
openaire   +3 more sources

Dopamine, T cells and multiple sclerosis (MS) [PDF]

Journal of Neural Transmission, 2017
Dopamine is a key neurotransmitter that induces critical effects in the nervous system and in many peripheral organs, via 5 dopamine receptors (DRs): D1R-D5R. Dopamine also induces many direct and very potent effects on many DR-expressing immune cells, primarily T cells and dendritic cells.
Levite, Mia, MARINO, FRANCA, COSENTINO, MARCO   +2 more
openaire   +2 more sources

Fulminant multiple sclerosis (MS)

Neurological Sciences, 2011
Fulminant multiple sclerosis (MS) is the most malignant form of MS which usually leads to death in few weeks. Although it can be accompanied by optic neuritis (ON), but long interval between ON and the grave onset has not been reported. Fulminant MS usually occurs as the first onset and previous ON is not common.
Shadi Ghourchian, Mohammad Rohani
openaire   +3 more sources

Patient with Multiple Sclerosis (MS)

2020
Pain is a prevalent and debilitating symptom of multiple sclerosis (MS) often requiring inpatient management. This chapter demonstrates medical management of pain in multiple sclerosis patients. Beginning with epidemiology of pain requiring inpatient management, the prevalence and pathophysiology of pain will be discussed.
Navdeep Jassal, Chandni B. Patel, Ankur A. Patel   +2 more
openaire   +2 more sources